【レポートの概要(一部)】
1. Report Overview
1.1 Global Asthma and COPD Therapies Market Overview
1.2 Global Asthma and COPD Therapies Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2. Introduction to Asthma and COPD Therapies
2.1 The Pharmaceutical Industry: a Very Brief Overview
2.2 Overview of Respiratory Diseases
2.2.1 Classifying Respiratory Diseases: Obstructive and Restrictive
2.3 What is Asthma?
2.3.1 Trends in Asthma Prevalence
2.3.2 Pathophysiology of Asthma
2.3.3 Symptoms of Asthma
2.3.4 Causes and Triggers for Asthma
2.3.5 Treatment of Asthma
2.3.6 Guidelines for Asthma Treatment
2.3.7 Drug Treatments for Asthma
2.3.8 Drug Delivery Methods in Asthma
2.4 What is Chronic Obstructive Pulmonary Disease (COPD)?
2.4.1 Trends in COPD Prevalence
2.4.2 Pathophysiology of COPD
2.4.3 Signs and Symptoms of COPD
2.4.4 Treatment of COPD
2.4.5 Drug Treatments for COPD
2.4.6 Guidelines for COPD Treatment
2.5 Major Drug Classes in the Treatment of Asthma and COPD
2.5.1 Bronchodilators
2.5.1.1 Beta2-Agonists
2.5.1.2 Anticholinergics
2.5.2 Anti-Inflammatory Drugs
2.5.2.1 Corticosteroids
2.5.2.2 Leukotriene Receptor Antagonists
2.5.2.3 Monoclonal Antibodies in the Treatment of Respiratory Disease
2.5.3 Combination Drugs
2.5.4 Drugs for Allergic Rhinitis
2.6 Phases of Clinical Trials
2.7 Scope of this Report
2.8 Currency Exchange Rates in This Report
3. Asthma and COPD Therapies: World Market 2014-2024
3.1 The World Respiratory Drugs Market by Therapeutic Area
3.2 The World Asthma and COPD Therapies Market in 2013
3.2.1 Leading Asthma and COPD Therapies
3.2.2 Leading Companies in the Asthma and COPD Therapies Market
3.3 World Asthma and COPD Therapies Market: Sales Forecast by Therapeutic Area, 2014-2024
3.3.1 World Asthma Therapies Market: Sales Forecast 2014-2024
3.3.2 World COPD Therapies Market: Sales Forecast 2014-2024
3.4 World Asthma and COPD Therapies Market: Sales Forecast by Drug Class 2014-2024
3.5 Combination Drugs Lead the Asthma and COPD Therapies Market
3.6 How Will Segmental Market Shares Change to 2024?
3.6.1 World Asthma and COPD Therapies Market: Drivers and Restraints 2014-2024
3.7 Asthma and COPD Therapies: Trends and Developments
3.7.1 FDA Requires Replacement of CFC Inhalers with HFA Inhalers
3.7.2 The WISDOM Trial: Will Steroids Lose Their Role in COPD?
4. Leading National Markets 2014-2024
4.1 Regional Breakdown of the World Asthma and COPD Therapies Market
4.2 World Asthma and COPD Therapies Market: Regional Forecast 2014-2024
4.2.1 How Will Regional Market Shares Change to 2024?
4.3 National Breakdown of the World Asthma and COPD Therapies Market
4.4 World Asthma and COPD Therapies Market: National Markets Forecast 2014-2024
4.4.1 How Will National Market Shares Change to 2024?
4.5 The US Asthma and COPD Therapies Market 2014-2024
4.5.1 US Asthma and COPD Therapies Market Forecast 2014-2024
4.5.2 US Asthma and COPD Therapies Market: Trends and Developments
4.5.2.1 Increasing COPD Prevalence in the US
4.5.2.2 FDA Issues Draft Guidance on Generic Inhaler Bioequivalence
4.5.2.3 Pharmacy Benefit Managers Alter Formulary Status of Advair
4.6 Japanese Asthma and COPD Therapies Market 2014-2024
4.6.1 Japanese Asthma and COPD Therapies Market Forecast 2014-2024
4.6.2 Japanese Asthma and COPD Therapies Market: Trends and Developments
4.6.2.1 Generic Penetration to Reach 60% by 2018?
4.6.2.2 Japanese Pharmaceutical Industry Regulatory Reform
4.7 EU5 Asthma and COPD Therapies Market 2014-2024
4.7.1 German Asthma and COPD Therapies Market Forecast 2014-2024
4.7.2 French Asthma and COPD Therapies Market Forecast 2014-2024
4.7.3 UK Asthma and COPD Therapies Market Forecast 2014-2024
4.7.4 Italian Asthma and COPD Therapies Market Forecast 2014-2024
4.7.5 Spanish Asthma and COPD Therapies Market Forecast 2014-2024
4.7.6 EU5 Asthma and COPD Therapies Market: Trends and Developments
4.7.6.1 Germany: Reform of AMNOG Pharmaceutical Rebate Law
4.7.6.2 France: Social Security Finance Bill 2014
4.7.6.3 UK: Improving Asthma and COPD Patient Outcomes
4.7.6.4 Italy: Austerity Measures Limiting Growth
4.7.6.5 Spain: The Start of Recovery in the Spanish Economy
4.8 BRIC Asthma and COPD Therapies Market 2014-2024
4.8.1 Chinese Asthma and COPD Therapies Market Forecast 2014-2024
4.8.2 Chinese Asthma and COPD Therapies Market: Trends and Developments
4.8.2.1 China’s Industrial Future and Asthma/COPD
4.8.2.2 Expansion of Healthcare Coverage and Reimbursement
4.8.2.3 Price Controls and the Anhui Model
4.8.3 Brazilian Asthma and COPD Therapies Market Forecast 2014-2024
4.8.4 Brazilian Asthma and COPD Therapies Market: Trends and Developments
4.8.4.1 Increasing Access to Medicines
4.8.5 Indian Asthma and COPD Therapies Market Forecast 2014-2024
4.8.6 Indian Asthma and COPD Therapies Market: Trends and Developments
4.8.6.1 Drug Prices Control Order 2013
4.8.6.2 Expansion of Healthcare Provision
4.8.7 Russian Asthma and COPD Therapies Market Forecast 2014-2024
4.8.8 Russian Asthma and COPD Therapies Market: Trends and Developments
4.8.8.1 No Embargo on Foreign Drug Imports
4.8.8.2 Pharma2020 and the Russian Pharmaceutical Industry
4.9 Mexican Asthma and COPD Therapies Market 2014-2024
4.9.1 Mexican Asthma and COPD Therapies Market Forecast 2014-2024
4.9.2 Mexican Asthma and COPD Therapies Market: Trends and Developments
4.9.2.1 Seguro Popular: Mexican Healthcare Reform
4.9.2.2 COFEPRIS: Regulatory Changes and Improvements
4.9.2.3 Mexico’s Agreement for Innovation
5. Bronchodilator Monotherapy Market 2014-2024
5.1 Introduction to Bronchodilator Monotherapy
5.2 The Bronchodilator Monotherapy Market in 2013
5.2.1 Leading Bronchodilators in 2013
5.3 Bronchodilator Monotherapy: Market Forecast 2014-2024
5.4 How Will Market Shares by Drug Class Change to 2024?
5.5 The Short-Acting Beta2-Agonist (SABA) Market 2014-2024
5.5.1 Leading SABAs in 2013
5.5.2 SABAs: Market Forecast 2014-2024
5.5.3 Market Share of Leading SABAs to 2024
5.5.4 Ventolin (salbutamol, GSK)
5.5.4.1 Ventolin: Sales Forecast 2014-2024
5.5.5 ProAir (salbutamol, Teva)
5.5.5.1 ProAir: Sales Forecast 2014-2024
5.5.6 Proventil (salbutamol, Merck)
5.5.6.1 Proventil: Sales Forecast 2014-2024
5.5.7 Xopenex (levosalbutamol, Dainippon Sumitomo)
5.5.7.1 Xopenex: Sales Forecast 2014-2024
5.6 The Long-Acting Beta2-Agonist (LABA) Market 2014-2024
5.6.1 Leading LABAs in 2013
5.6.2 LABAs: Market Forecast 2014-2024
5.6.3 Market Share of Leading LABAs to 2024
5.6.4 Foradil (formoterol, Merck/Novartis)
5.6.4.1 Foradil: Sales Forecast 2014-2024
5.6.5 Serevent (salmeterol, GSK)
5.6.5.1 Serevent: Sales Forecast 2014-2024
5.6.6 Arcapta/Onbrez (indacaterol, Novartis)
5.6.6.1 Arcapta/Onbrez: Sales Forecast 2014-2024
5.6.7 Brovana (arfomoterol, Dainippon Sumitomo)
5.6.7.1 Brovana: Sales Forecast 2014-2024
5.6.8 Striverdi (olodaterol, Boehringer Ingelheim)
5.6.8.1 Striverdi: Sales Forecast 2014-2024
5.7 The Anticholinergics Market 2014-2024
5.7.1 Leading Anticholinergics in 2013
5.7.2 Anticholinergics: Market Forecast 2014-2024
5.7.3 Market Share of Leading Anticholinergics to 2024
5.7.4 Spiriva (tiotropium, Boehringer Ingelheim)
5.7.4.1 Spiriva: Sales Forecast 2014-2024
5.7.5 Spiriva: Recent Developments
5.7.5.1 Safety Concerns and the UPLIFT Trial
5.7.5.2 Results of the POET Study
5.7.5.3 Competition from Combination Products
5.7.6 Atrovent (ipratropium, Boehringer Ingelheim)
5.7.6.1 Atrovent: Sales Forecast 2014-2024
5.7.7 Eklira/Tudorza/Bretaris (aclidinium, AstraZeneca/Forest/Menarini)
5.7.7.1 Eklira/Tudorza/Bretaris: Sales Forecast 2014-2024
6. Anti-Inflammatory Drugs Market 2014-2024
6.1 Introduction to Anti-Inflammatory Drugs
6.2 The Anti-Inflammatory Drugs Market in 2013
6.2.1 Leading Anti-Inflammatory Drugs in 2013
6.3 Anti-Inflammatory Drugs: Market Forecast 2014-2024
6.4 How Will Market Shares by Drug Class Change to 2024?
6.5 The Corticosteroids Market 2014-2024
6.5.1 Leading Corticosteroids in 2013
6.5.2 Corticosteroids: Market Forecast 2014-2024
6.5.3 Market Share of Leading Corticosteroids to 2024
6.5.4 Flixotide/Flovent (fluticasone propionate, GSK)
6.5.4.1 Flixotide/Flovent: Sales Forecast 2014-2024
6.5.5 Pulmicort (budesonide, AstraZeneca)
6.5.5.1 Pulmicort: Sales Forecast 2014-2024
6.5.6 QVAR (beclometasone, Teva)
6.5.6.1 QVAR: Sales Forecast 2014-2024
6.5.7 Asmanex (mometasone, Merck)
6.5.7.1 Asmanex: Sales Forecast 2014-2024
6.6 The Anti-Leukotrienes Market 2014-2024
6.6.1 Leading Anti-Leukotrienes in 2013
6.6.2 Anti-Leukotrienes: Market Forecast 2014-2024
6.6.2.1 Market Share of Leading Anti-Leukotrienes to 2024
6.6.3 Singulair (montelukast, Merck)
6.6.3.1 Singulair: Sales Forecast 2014-2024
6.7 The Monoclonal Antibodies Market 2014-2024
6.7.1 Monoclonal Antibodies: Market Forecast 2014-2024
6.7.1.1 Market Share of Leading Monoclonal Antibodies to 2024
6.7.2 Xolair (omalizumab, Novartis/Roche)
6.7.2.1 Xolair: Sales Forecast 2014-2024
6.7.3 Cinquil (reslizumab, Teva)
6.7.3.1 Cinquil: Sales Forecast 2014-2024
6.7.4 Mepolizumab (Bosatria, GSK)
6.7.4.1 Mepolizumab: Sales Forecast 2014-2024
6.7.5 Benralizumab (MEDI-563, AstraZeneca/Kyowa Hakko Kirin)
6.7.5.1 Benralizumab: Sales Forecast 2014-2024
6.7.6 Lebrikizumab (RG3637, Roche)
6.7.6.1 Lebrikizumab: Sales Forecast 2014-2024
6.7.7 Dupilumab (REGN668, Regeneron/Sanofi)
6.7.7.1 Dupilumab: Sales Forecast 2014-2024
7. Combination Drugs Market 2014-2024
7.1 Introduction to Combination Drugs
7.1.1 Leading Combination Drugs in 2013
7.2 Combination Drugs: Market Forecast 2014-2024
7.3 How Will Market Shares by Drug Change to 2024?
7.3.1 Advair/Seretide (fluticasone/salmeterol, GSK)
7.3.1.1 Advair/Seretide: Sales Forecast 2014-2024
7.3.2 Symbicort (budesonide/formoterol, AstraZeneca)
7.3.2.1 Symbicort: Sales Forecast 2014-2024
7.3.2.2 Symbicort: The SMART Concept
7.3.3 Combivent (ipratropium/salbutamol, Boehringer Ingelheim)
7.3.3.1 Combivent: Sales Forecast 2014-2024
7.3.4 Dulera (formoterol/mometasone, Merck)
7.3.4.1 Dulera: Sales Forecast 2014-2024
7.4 Recently Launched Combination Drugs
8. Leading Companies in the Asthma and COPD Therapies Market
8.1 Asthma and COPD Therapies: Increasing Competition
8.1.1 Leading Companies in Asthma and COPD in 2013
8.1.2 Leading Companies: Market Forecast 2014-2024
8.1.3 How Will Leading Companies’ Market Shares Change to 2024?
8.2 AstraZeneca
8.2.1 AstraZeneca: Asthma and COPD Therapies
8.2.2 AstraZeneca: Sales Forecast 2014-2024
8.2.3 AstraZeneca: Products in Development
8.2.4 AstraZeneca: Recent Developments
8.2.4.1 AstraZeneca Acquires Almirall’s Respiratory Portfolio
8.2.4.2 Acquisition of Pearl Therapeutics Expanded AstraZeneca’s Combination Drug Pipeline
8.2.4.3 AstraZeneca Rejects Pfizer Takeover Bid
8.3 Boehringer Ingelheim
8.3.1 Boehringer Ingelheim: Asthma and COPD Therapies
8.3.2 Boehringer Ingelheim: Sales Forecast 2014-2024
8.3.3 Boehringer Ingelheim: Products in Development
8.3.4 Boehringer Ingelheim: Recent Developments
8.3.4.1 Expansion of Respimat Manufacturing Capacity
8.3.4.2 Respimat Safety Concerns and the TIOSPIR Study
8.3.4.3 Ben Venue Laboratories Shut Down
8.4 GSK
8.4.1 GSK: Asthma and COPD Therapies
8.4.2 GSK: Sales Forecast 2014-2024
8.4.3 GSK: Products in Development
8.4.4 GSK: Recent Developments
8.4.4.1 Breo/Relvar and Anoro: Recently Launched Combination Drugs
8.4.4.2 Arnuity Ellipta Approved in the US
8.4.4.3 GSK Divests OTC Products
8.4.4.4 GSK Asset Swap with Novartis to Restructure Consumer Health
8.4.4.5 GSK Presents Data on Eosinophil Levels and COPD
8.5 Merck & Co. (Merck)
8.5.1 Merck: Asthma and COPD Therapies
8.5.2 Merck: Sales Forecast 2014-2024
8.5.3 Merck: Products in Development
8.5.4 Merck: Recent Developments
8.5.4.1 Bayer Acquires Merck’s Consumer Health Business
8.5.4.2 FDA Rejects Singulair OTC Switch
8.5.4.3 Takeda Ended Co-Promotion of Daxas with Merck
8.6 Novartis
8.6.1 Novartis: Asthma and COPD Therapies
8.6.2 Novartis: Sales Forecast 2014-2024
8.6.3 Novartis: Products in Development
8.6.4 Novartis: Recent Developments
8.6.4.1 Novartis Restructures Following Strategic Review
8.6.4.2 Novartis Presents Data on Ultibro and Seebri
8.6.4.3 Pfizer Promotes Two Novartis COPD drugs in the UK
8.7 Roche
8.7.1 Roche: Asthma and COPD Therapies
8.7.2 Roche: Sales Forecast 2014-2024
8.7.3 Roche: Products in Development
8.8 Teva
8.8.1 Teva: Asthma and COPD Therapies
8.8.2 Teva: Sales Forecast 2014-2024
8.8.3 Teva: Products in Development
8.8.4 Teva: Recent Developments
8.8.4.1 Launch of DuoResp Spiromax
【レポート販売概要】
■ タイトル:世界の喘息及びCOPD(慢性閉塞性肺疾患)治療薬市場■ 英文:Asthma and COPD Therapies Market Forecast 2014-2024 : Opportunities for Leading Companies
■ 発行日:2014年10月
■ 調査会社:visiongain
■ 商品コード:VGAIN4120203
■ 調査対象地域:グローバル
- 防湿絶縁コーティングの世界市場:アクリル塗料、エポキシ塗料、ウレタン塗料、シリコーン塗料、パリレン塗料The global conformal coatings market is estimated to reach USD 12.28 Billion by 2021, registering a CAGR of 4.7% between 2016 and 2021. The market is driven by increasing demand for conformal coatings in emerging markets and high demand from printed circuit boards in electronics and automotive & transportation industries. Conformal coatings have unique properties, such as high resistance to dust, …
- 業務用フードプロセッサーの世界市場2017-2021About Commercial Food ProcessorsCommercial food processors are versatile and valuable appliances that help in grinding meat, kneading dough, and puree soups. The control systems of commercial food processors are laid out in a simple configuration that helps a foodservice operator to use them with ease. These processors are used in improving efficiency and hence the overall productivity in commerci …
- グローバル画像診断装置(医療機器)メーカー分析(技術能力、戦略、課題):EsaoteThe strategic assessment of Esaote, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in th …
- 世界のペプチドワクチン(Peptide Vaccine)市場Peptide vaccines are peptides that exhibit pharmacological properties by activating human immune system rather than showing pharmacologically activity by themselves. They are administered into body to enter in lymph nodes where they induce long lasting immune response. They utilize immune system and develop long term acquired immunity which has capability to prevent future incidences of pathogen a …
- 自動調剤機の世界市場2015-2019About Automated Dispensing Machines An automated dispensing machine is a computerized dispensing and drug storage device, which is used by healthcare facilities such as hospitals and pharmacies. These machines are located at the POC such as the ICU, the ward, and ED. The automated dispensing system is integrated with the main medication information system and functions as a decentralized distribut …
- 家庭用防犯カメラの世界市場展望2017-20276According to Stratistics MRC, the Global Home Security Cameras Market is accounted for $2.76 million in 2017 and is expected to reach $8.78 million by 2026 growing at a CAGR of 13.7% during the forecast period. Some of the key factors influencing the market growth include growing adoption of smart homes, increasing awareness regarding security and safety and ease of installation of security camera …
- 坑井試験サービスの世界市場:リアルタイム坑井試験、ダウンホール坑井試験、リザーバサンプリング、表面坑井試験This report estimates the well testing market in terms of value in $million. This has been broken down into component regions and further split into countries. The oil &gas industry witnesses high number of the E&P activities every year which is undertaken to meet the growing global energy demand. Well test is an essential part of the well lifecycle and is used on the exploration, appraisal, and d …
- 産業用ジャガイモ選別機の世界市場2018-2022About Industrial Potato Graders Potato graders are used to grade potatoes before they are used for processing activities. Graders help in grading potatoes based on various characteristics, including size, weight, and shape. Technavio’s analysts forecast the global industrial potato graders market to grow at a CAGR of 4.95% during the period 2018-2022. Covered in this report The report covers the p …
- Belviq(肥満治療薬):市場予測及び分析(~2022)Belviq (Obesity) - Forecast and Market Analysis to 2022 Summary After a more than decade-long dormancy, the obesity market is undergoing a revival with the advent of several novel therapies that will lend considerable visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molec …
- 世界の酪農食品(乳製品)市場のニュース及びイベント動向(2014年6月)Synopsis The report provides a review of the latest news and key events in the global dairy food market during June 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global dairy food market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the global …
- 中東(GCC)の消火器市場2016-2020About GCC Fire Extinguisher The rising levels of urbanization, supported by infrastructure development projects in the GCC, is the key growth driver behind the demand for fire extinguishers. The Civil defense department in GCC has also laid down guidelines that the building owners need to follow while operating different types of buildings. The Occupational Health and Safety Administration (OSHA) …
- コンテンツデリバリーネットワーク(CDN)の世界市場Adoption of cloud services, BYOD, CYOD, and mobility adoption trend is increasing. It has made business operations easy for such organizations, but has also increased the complexity for the network providers and page administrators to manage and deliver their contents efficiently. The organizations whose business depends upon the internet started facing difficulties, such as latency and network co …
- 複合材料の世界市場:炭素繊維複合材、ガラス繊維複合材、アラミド繊維複合材、天然繊維複合材The composites market size of end products in terms of value is projected to reach around $90 billion by 2020 and expected to grow at a CAGR of 7% to 9% between 2015 and 2020. Asia-Pacific held the largest share by volume in composites market in 2014. Major growth in the Asia-Pacific region is expected from the growing construction, aerospace and electronics & semiconductor application. The compos …
- 殺菌剤の世界市場予測(~2022年):ベンズイミダゾール、ジチオカルバメート、フェニルアミド、クロロニトリル、ストロビルリン、トリアゾールThe fungicides market is projected to grow at a CAGR of 4.78% to reach USD 19.17 Billion by 2022. The market growth is driven by the rise in need for food security for the growing population, advancement in farming practices and technologies, and ease of application of fungicides. The market is further driven by factors such as increase in demand for fruits and vegetables, along with increase in a …
- ガラクトオリゴ糖(GOS)の世界市場の動向分析:用途別(食品・飲料、栄養補助食品)、地域別(北アメリカ、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東、アフリカ)、セグメント予測、2014-2025The global galacto-oligosaccharide (GOS) market is expected to reach a market size of USD 1.69 billion by 2025, according to a new report by Grand View Research, Inc. Changing consumer lifestyles coupled with increasing number of working women in the developing economies is likely to have a positive impact on the market growth over the forecast period. GOS is used as low-calorie sweetener & food i …